Sabby Management’s Celgene Corp CELG Stock Holding History

Sabby Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-37,728	Closed	-$3.94M	–	366
2016 Q3	$3.94M	Buy	+37,728	New	+$4.08M	0.15%	87
2015 Q2	–	Sell	-22,225	Closed	-$2.56M	–	401
2015 Q1	$2.56M	Buy	+22,225	New	+$2.66M	0.11%	123
2014 Q2	–	Sell	-38,998	Closed	-$2.97M	–	315
2014 Q1	$2.72M	Buy	+38,998	New	+$3.09M	0.15%	93

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sabby Management's CELG Position: Q4 2016 in Review

Sabby Management sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 37,728 shares — an estimated $3.94M sold.

Sabby Management first reported a position in CELG in Q1 2014 and held it in 3 quarters. The position peaked at $3.94M in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

Sabby Management reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
Sabby Management sold 37,728 Celgene Corp shares in Q4 2016, an estimated $3.94M.
Sabby Management first reported a position in Celgene Corp in Q1 2014 and held it in 3 quarters.
Sabby Management's Celgene Corp position peaked at $3.94M in Q3 2016.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.